DaviesT. Growing an interest in autoimmune thyroid disease—an interview with Robert Volpe MD. Endocrinology and Metabolism Clinics of North Americs, 2000; 29(2):431–442.
2.
McKenzieJM. A thyroid-stimulating life: An interview with Dr. J. Maxwell McKenzie. Thyroid, 2001; 11(11):1035–1042.
3.
DaviesT. Braverman’s Thyroid—An interview with Lewis Braverman. Thyroid, 2005; 15(3):188–196.
4.
DaviesTF. The scientific contributions of Martin Surks, MD, MACP: A pioneer in thyroid hormone physiology, subclinical hypothyroidism, and endocrine education. Thyroid, 2022; 32(7):745–749.
5.
DaviesTF. The active times of Jerome Hershman, MD: An interview with the founding editor of thyroid about a life devoted to the thyroid gland (and other things). Thyroid, 2021; 31(11):1609–1612.
6.
DaviesTF. An accidental thyroidologist: Sandra McLachlan, PhD. Thyroid, 2024; 34(3):281–287.
7.
DaviesTF. A discussion with Leonard Wartofsky, MD: Teacher, clinician, investigator, mentor of many, a medical politician, and guest editor of thyroid volume 1 number 1. Thyroid, 2023; 33(12):1387–1392.
8.
RitchieD. Doing oral history: a practical guide. Oxford University Press; 2003.
9.
FromkinD. A peace to end all peace: Henry Holt and company. New York; 2009.
10.
NadlerNJ, LeblondCP, CarneiroJ. Site of formation of thyroglobulin in mouse thyroid as shown by radioautography with leucine-H3. Proc Soc Exp Biol Med, 1960; 105:38–41.
11.
SelyeH. The nature of stress. Basal Facts, 1985; 7(1):3–11.
12.
SalterW. Protein-bound iodine in blood. 6. Its relation to thyroid function in 100 clinical cases. American Journal of Medicine, 1941; 202:527–642.
MurphyB. Application of the property of protein-binding to the assay of minute quantities of hormones and other substances. Nature, 1964; 201:679–682.
15.
RefetoffS. Iatrogenic hydrothorax. Report of a case. Ann Intern Med, 1965; 63(5):869–872.
16.
RefetoffS, DeWindLT, DeGrootLJ. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: Possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab, 1967; 27(2):279–294.
17.
SelenkowHA, KarpPJ. An approach to therapy and diagnosis of thyroid tumors. Semin Nucl Med, 1971; 1(4):461–473.
18.
RefetoffS, DeGrootLJ, BenardB, et al.Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism, 1972; 21(8):723–756.
19.
RefetoffS, SelenkowHA. Familial thyroxine-binding globulin deficiency in a patient with Turner’s syndrome (XO). Genetic study of a kindred. N Engl J Med, 1968; 278(20):1081–1087.
20.
LambergBA. Congenital euthyroid goitre and partial peripheral resistance to thyroid hormones. Lancet, 1973; 1(7808):854–857.
21.
BodeHH, DanonM, WeintraubBD, et al.Partial target organ resistance to thyroid hormone. J Clin Invest, 1973; 52(4):776–782.
22.
SterlingK, RefetoffS, SelenkowHA. T3 thyrotoxicosis. Thyrotoxicosis due to elevated serum triiodothyronine levels. JAMA, 1970; 213(4):571–575.
23.
Van CauterE, RefetoffS. Evidence for two subtypes of Cushing’s disease based on the analysis of episodic cortisol secretion. N Engl J Med, 1985; 312(21):1343–1349.
24.
GolsteinJ, Van CauterE, DesirD, et al.Effects of “jet lag” on hormonal patterns. IV. Time shifts increase growth hormone release. J Clin Endocrinol Metab, 1983; 56(3):433–440.
25.
WeinbergerC, ThompsonCC, OngES, et al.The c-erb-A gene encodes a thyroid hormone receptor. Nature, 1986; 324(6098):641–646.
26.
SapJ, MunozA, DammK, et al.The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature, 1986; 324(6098):635–640.
27.
UsalaSJ, BaleAE, GesundheitN, et al.Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol, 1988; 2(12):1217–1220.
28.
SakuraiA, TakedaK, AinK, et al.Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A, 1989; 86(22):8977–8981.
29.
RefetoffS, ScherbergNH, YuanC, et al.Free thyroxine concentrations in sera of individuals with familial dysalbuminemic hyperthyroxinemia: A comparison of three methods of measurement. Thyroid, 2020; 30(1):37–41.
30.
SunthornthepvarakulT, AngkeowP, WeissRE, et al.An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun, 1994; 202(2):781–787.
31.
DumitrescuAM, LiaoXH, AbdullahMS, et al.Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet, 2005; 37(11):1247–1252.
32.
SunthornthepvarakulT, GottschalkME, HayashiY, et al.Brief report: Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med, 1995; 332(3):155–160.
33.
ParmaJ, DuprezL, Van SandeJ, et al.Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature, 1993; 365(6447):649–651.
34.
GrasbergerH, DumitrescuAM, LiaoXH, et al.STR mutations on chromosome 15q cause thyrotropin resistance by activating a primate-specific enhancer of MIR7-2/MIR1179. Nat Genet, 2024; 56(5):877–888.
35.
AlieskyH, CourtneyCL, RapoportB, et al.Thyroid autoantibodies are rare in nonhuman great apes and hypothyroidism cannot be attributed to thyroid autoimmunity. Endocrinology, 2013; 154(12):4896–4907.
36.
MartinoE, SafranM, Aghini-LombardiF, et al.Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med, 1984; 101(1):28–34.
37.
PohlenzJ, DuprezL, WeissRE, et al.Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab, 2000; 85(7):2366–2369.
38.
PohlenzJ, DumitrescuA, ZundelD, et al.Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest, 2002; 109(4):469–473.
39.
GrasbergerH, De DekenX, MiotF, et al.Missense mutations of dual oxidase 2 (DUOX2) implicated in congenital hypothyroidism have impaired trafficking in cells reconstituted with DUOX2 maturation factor. Mol Endocrinol, 2007; 21(6):1408–1421.
